• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Dogwood Therapeutics Announces 2024 Financial Results

    GLOBENEWSWIRE

    Dogwood Therapeutics Doses First Patient in Halneuron® Trial

    GLOBENEWSWIRE

    Dogwood Therapeutics, Inc. Announces $4.8M Stock Offering

    GLOBENEWSWIRE

    Dogwood Therapeutics, Inc. Converts $19.5M Debt to Equity

    GLOBENEWSWIRE

    Dogwood Starts Phase 2b Halneuron® Trial For CINP In Early 2025

    GLOBENEWSWIRE

    Dogwood Therapeutics Announces Low Dose IMC-2 Reduces Long-COVID

    GLOBENEWSWIRE

    Dogwood Therapeutics Announces Q3 2024 Financial Results

    GLOBENEWSWIRE

    Dogwood Therapeutics to Report Q3 2024 Results on Nov 7, 2024

    GLOBENEWSWIRE

    Dogwood Therapeutic Regain Compliance with Nasdaq Minimum Bid Price

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.